Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

NCT05673629 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

552

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Utidelone Injection in combination with AC
DRUG: Docetaxel Injection in combination with AC

Sponsor

Beijing Biostar Pharmaceuticals Co., Ltd.